Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

AbbVie CEO's pay doubles to $18.2M in Abbott pharma spinoff's first solo year

25.03.2014 / Fierce Pharma

AbbVie CEO Richard Gonzalez has been on the job for just over a year, and already his pay has more than doubled. As chief of the newly minted pharma company, spun off from Abbott Laboratories last January 1, Gonzalez racked up $18.2 million in 2013 compensation, including $3.3 million in incentive pay.

Cover_HCLS_GREECE LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: